Benitec Biopharma Inc. (BNTC) Financial Statements
Free cash flow over the same period: -$16.6M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
BNTCBenitec Biopharma Inc.Follow BNTC — free
—
Price chart with a free account
- Market cap
- 301.7M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 12 Nov, in 19 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2020 Jun 20 | FY2021 Jun 21 | FY2022 Jun 22 | FY2023 Jun 23 | FY2024 Jun 24 | FY2025 Jun 25 | FY2026 Jun 26 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|
| Research & development | 3.0 | 7.0 | 11.3 | 12.8 | 15.6 | 18.3 | 23.4 | 23.4 | |
| Operating income | -8.3 | -13.6 | -17.9 | -19.1 | -22.5 | -41.8 | -51.2 | -51.2 | |
| Pre-tax income | -8.3 | -13.9 | -18.2 | -19.6 | -21.8 | -37.9 | -45.5 | -45.5 | |
| Income tax | — | — | — | — | — | — | 0.0 | — | |
| Net income | -8.3 | -13.9 | -18.2 | -19.6 | -21.8 | -37.9 | -45.5 | -45.5 | |
| Diluted EPS ($) | -8.10 | -3.23 | -37.88 | -14.12 | -1.22 | -1.05 | -0.98 | -0.98 | |
| Diluted shares (mn) | — | — | 0.5 | 1.4 | 18.4 | 36.2 | 46.6 | — |
USD millions · SEC XBRL
Benitec Biopharma Inc. — questions
- What is Benitec Biopharma Inc.'s net income?
- -$45.5M over the twelve months to 2026-06-30.
- What is Benitec Biopharma Inc.'s free cash flow?
- -$16.6M over the twelve months to 2026-06-30.
- What are Benitec Biopharma Inc.'s diluted earnings per share?
- $-0.98 over the twelve months to 2026-06-30.
Every figure on this page comes from Benitec Biopharma Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.